Swine flu vaccine effective despite mutations: experts

November 21, 2009

Swine flu vaccines are still effective despite reported cases of mutations in the A(H1N1) virus, health experts in Europe and North America said Saturday.

Bruno Lina, director of the national flu monitoring centre for southern France, said the mutation of the virus -- blamed for around 6,750 deaths so far worldwide -- came as no surprise.

"It was expected, it was announced, and it will happen again," Lina told AFP, adding: "That does not change anything with regard to treatment and vaccines."

In the United States, Anne Schuchat of the Centres for Disease Control (CDC) said the mutation would have no impact on the effectiveness of the vaccine or the anti-virals.

The experts' comments came a day after the World Health Organization announced that a mutation had been found in swine samples taken following the first two deaths from the pandemic in Norway.

However, the Geneva-based UN agency stressed that the mutation did not appear to cause a more contagious or more dangerous form of A(H1N1).

It also revealed that a similar mutation had been observed in Brazil, China, Japan, Mexico, Ukraine and the United States as early as April.

The WHO underlined that there was no evidence of more infections or more deaths as a result, while antivirals used to treat severe flu -- () and () -- are effective on the mutated virus.

"Studies show that currently available pandemic vaccines confer protection," it added, as mass vaccine campaigns slowly gain ground in the northern hemisphere.

That view was echoed opn Saturday by France's health chief, Didier Houssin, who said in a radio interview that the ability of the vaccine to induce an immune reaction is not affected by the mutation, "so the vaccines remain effective".

He added that in anticipation of a mutation, "a certain number of our vaccines are vaccines with an additive," which expands the range of effectiveness in being able to act against a slightly modified virus.

Scientists are nevertheless concerned that mutations in flu viruses could cause a more virulent and deadly pandemic flu.

In the cases observed in Norway, the mutation could potentially allow the virus to latch onto the pulmonary cells -- that is, deep inside the lungs, which is generally considered a more dangerous form.

"At the moment we are purely at a descriptive stage," Lina said.#

"It will have to be verified if these viruses have acquired a particular characteristic which could potentially make them more likely and more easily to take a pulmonary form."

On Friday, data showed that around 6,750 people had died from swine flu since the virus was first uncovered in Mexico and the United States in April.

(c) 2009 AFP

Related Stories

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Nov 21, 2009
"That view was echoed opn Saturday by France's health chief, Didier Houssin, who said in a radio interview that the ability of the vaccine to induce an immune reaction is not affected by the mutation, "so the vaccines remain effective"."

Thats baloney because the immune reaction is "boosted" by adjuvants like squalene.
Its not the body reacting to the virus!!!

Thats why they are dangerous. They cause the body to overreact and form mini clots in the capillaries from too many white blood cells..

Vaccines are dangerous unless they are clean from mercury, squalene, dead tissue, chemicals etc. The drug companies dont spend the time to make a good vaccine.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.